Contractile effects of albiglutide in the human and mouse atrium - Takeaways - MDSpire

Contractile effects of albiglutide in the human and mouse atrium

  • By

  • Joachim Neumann

  • Milena Jarikova

  • Uwe Kirchhefer

  • Britt Hofmann

  • Ulrich Gergs

  • July 3, 2026

  • 0 min

Share

  • 1

    Albiglutide is a GLP-1 receptor agonist developed for treating type 2 diabetes and shows a positive inotropic effect in human atrial preparations.

  • 2

    The positive inotropic effect of albiglutide in human atrial preparations is time- and concentration-dependent, starting at 10 nM and peaking at 100 nM.

  • 3

    Cilostamide enhances the inotropic effect of albiglutide, while propranolol does not reverse it, indicating a unique mechanism of action.

  • 4

    Albiglutide increases contractility through GLP-1 receptor stimulation and cAMP-dependent phosphorylation in human atrial preparations.

  • 5

    In contrast, albiglutide does not increase contractility in isolated atrial preparations from adult mice, suggesting species-specific effects.

Original Source(s)

Contractile effects of albiglutide in the human and mouse atrium

  • by Joachim Neumann, Milena Jarikova, Uwe Kirchhefer, Britt Hofmann, Ulrich Gergs

  • July 3, 2026

Related Content

Clinical value of perioperative myocardial strain assessment by transesophageal speckle-tracking echocardiography in patients undergoing off-pump coronary artery bypass grafting

Development of a risk score for intramyocardial hemorrhage in elderly STEMI patients after primary PCI: a retrospective cohort study with propensity score matching analysis

Editorial: Clinical Trials in Cardiovascular Medicine: 2025 — Addressing Residual Cardiovascular Risks Through Precision-Guided Approaches